ADAPTIMMUNE THERAPEUTICS PLC's ticker is ADAP and the CUSIP is 00653A107. A total of 88 filers reported holding ADAPTIMMUNE THERAPEUTICS PLC in Q2 2023. The put-call ratio across all filers is 0.40 and the average weighting 0.1%.
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management II, LLC | 1,054,864 | $8,597,000 | 5.88% |
| NEA Management Company, LLC | 9,880,999 | $80,530,000 | 4.18% |
| Abingworth LLP | 250,000 | $2,033,000 | 2.13% |
| New Leaf Venture Partners, L.L.C. | 127,041 | $1,035,000 | 0.89% |
| Iguana Healthcare Management, LLC | 200,000 | $1,630,000 | 0.66% |
| Rock Springs Capital Management LP | 765,001 | $6,235,000 | 0.46% |
| QVT Financial LP | 783,645 | $6,387,000 | 0.44% |
| Opaleye Management Inc. | 40,000 | $326,000 | 0.22% |
| Rathbones Group PLC | 450,525 | $3,672,000 | 0.20% |
| Virtus ETF Advisers LLC | 26,974 | $220,000 | 0.16% |